PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer.

导出 OA

翻译打印收藏纠错

作者： Santosh,Gupta ^[1] ; Susan,Halabi ^[2] ; Qian,Yang ^[2] ; Akash,Roy ^[2] ; Alisa,Tubbs ^[1] ; Yamini,Gore ^[1] ; Daniel J,George ^[3] ; David M,Nanus ^[4] ; Emmanuel S,Antonarakis ^[5] ; Daniel C,Danila ^[4] ; Russell Z,Szmulewitz ^[6] ; Richard,Wenstrup ^[1] ; Andrew J,Armstrong ^[3]

作者单位： Epic Sciences, San Diego, California. ^[1] Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina. ^[2] Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina. ^[3] Weill Cornell Medical College, New York, New York. ^[4] Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. ^[5] University of Chicago, Chicago, Illinois. ^[6]

主题词男(雄)性(Male);人类(Humans);肿瘤细胞, 循环(Neoplastic Cells, Circulating);治疗结果(Treatment Outcome);回顾性研究(Retrospective Studies);前瞻性研究(Prospective Studies)

DOI 10.1158/1078-0432.CCR-22-3233

PMID 36897758

发布时间 2024-06-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交